Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVIDStrategyCalculator: A standalone software to assess testing- and quarantine strategies for incoming travelers, contact person management and de-isolation

Wiep van der Toorn, Djin-Ye Oh, Daniel Bourquain, Janine Michel, Eva Krause, Andreas Nitsche, View ORCID ProfileMax von Kleist on behalf of the working group on SARS-CoV-2 Diagnostics at RKI
doi: https://doi.org/10.1101/2020.11.18.20233825
Wiep van der Toorn
1,2Systems Medicine of Infectious Disease (P5) and Bioinformatics (MF1), Methodology and Research Infrastructure, Robert Koch Institute Berlin, Germany
1,2Systems Medicine of Infectious Disease (P5) and Bioinformatics (MF1), Methodology and Research Infrastructure, Robert Koch Institute Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Djin-Ye Oh
3FG17 Influenza and other respiratory viruses, Department of Infectious Diseases, Robert Koch Institute Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Bourquain
4ZBS1 Highly pathogenic viruses, Center for Biological Threats And Special Pathogens, Robert Koch Institute Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janine Michel
4ZBS1 Highly pathogenic viruses, Center for Biological Threats And Special Pathogens, Robert Koch Institute Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Krause
4ZBS1 Highly pathogenic viruses, Center for Biological Threats And Special Pathogens, Robert Koch Institute Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Nitsche
4ZBS1 Highly pathogenic viruses, Center for Biological Threats And Special Pathogens, Robert Koch Institute Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Max von Kleist
1,2Systems Medicine of Infectious Disease (P5) and Bioinformatics (MF1), Methodology and Research Infrastructure, Robert Koch Institute Berlin, Germany
1,2Systems Medicine of Infectious Disease (P5) and Bioinformatics (MF1), Methodology and Research Infrastructure, Robert Koch Institute Berlin, Germany
5German COVID Omics Initiative (deCOI)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Max von Kleist
  • For correspondence: kleistm{at}rki.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

In early 2020 COVID-19 turned into a global pandemic. Non-pharmaceutical interventions (NPIs), including the isolation of infected individuals, tracing and quarantine of exposed individuals are decisive tools to prevent onwards transmission and curb fatalities. Strategies that combine NPIs with SARS-CoV-2 testing may help to shorten quarantine durations while being non-inferior with respect to infection prevention. Thus, combined strategies can help reducing the socio-economic burden of SARS-CoV2 and generate greater public acceptance. We developed a software that enables policy makers to calculate the reduction in transmissibility through quarantine or isolation in combination with arbitrary testing strategies. The user chooses between three different modi [(i) isolation of infected individuals, (ii) management of potentially infected contacts and (iii) quarantine of incoming travelers], while having total flexibility in customizing testing strategies, as well as setting model parameters. The software enables decision makers to tailor calculations specifically to their questions and perform an assessment ‘on the fly’, based on current evidence on infection dynamics.

Underneath, we analytically solve a stochastic transit compartment model of the infection time course, which captures temporal changes in test sensitivities, incubation- and infectious periods, as well as times to symptom onset using its default parameters.

Using default parameters, we estimated that testing travelers at the point of entry reduces the risk about 4.69 (4.19,4.83) fold for PCR vs. 3.59 (3.22, 3.69) fold for based rapid diagnostic tests (RDT, 87% relative sensitivity) when combined with symptom screening. In comparison to 14 days of pure quarantine, 8 (PCR) vs. 10 (RDT) days of pre-test quarantine would be noninferior for incoming travelers as well as for contact person management. De-isolation of infected individuals 11 days after symptom onset reduces the risk by >99fold (7.68,>1012).

This tool is freely available from: https://github.com/CovidStrategyCalculator/CovidStrategyCalculator

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

WvDT and MvK acknowledge funding from the Germany ministry for science and education (BMBF; grant numbers 01KI2016 and 031L0176A). D-YO acknowledges funding through the German ministry of health (BMG) as part of the COVID emergency crisis funds provided to RKI. The funders had no role in designing the research or the decision to publish.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • typos in Table 3 (PPV, NPV)

Data Availability

All data for reproducing the results is available as outlined in the manuscript.

https://github.com/CovidStrategyCalculator/CovidStrategyCalculator

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted November 19, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVIDStrategyCalculator: A standalone software to assess testing- and quarantine strategies for incoming travelers, contact person management and de-isolation
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVIDStrategyCalculator: A standalone software to assess testing- and quarantine strategies for incoming travelers, contact person management and de-isolation
Wiep van der Toorn, Djin-Ye Oh, Daniel Bourquain, Janine Michel, Eva Krause, Andreas Nitsche, Max von Kleist
medRxiv 2020.11.18.20233825; doi: https://doi.org/10.1101/2020.11.18.20233825
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
COVIDStrategyCalculator: A standalone software to assess testing- and quarantine strategies for incoming travelers, contact person management and de-isolation
Wiep van der Toorn, Djin-Ye Oh, Daniel Bourquain, Janine Michel, Eva Krause, Andreas Nitsche, Max von Kleist
medRxiv 2020.11.18.20233825; doi: https://doi.org/10.1101/2020.11.18.20233825

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Informatics
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (760)
  • Anesthesia (222)
  • Cardiovascular Medicine (3316)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (480)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13403)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5182)
  • Geriatric Medicine (483)
  • Health Economics (786)
  • Health Informatics (3286)
  • Health Policy (1146)
  • Health Systems and Quality Improvement (1199)
  • Hematology (432)
  • HIV/AIDS (1024)
  • Infectious Diseases (except HIV/AIDS) (14657)
  • Intensive Care and Critical Care Medicine (917)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (526)
  • Neurology (4957)
  • Nursing (263)
  • Nutrition (735)
  • Obstetrics and Gynecology (889)
  • Occupational and Environmental Health (797)
  • Oncology (2531)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1308)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (559)
  • Psychiatry and Clinical Psychology (4225)
  • Public and Global Health (7526)
  • Radiology and Imaging (1717)
  • Rehabilitation Medicine and Physical Therapy (1022)
  • Respiratory Medicine (982)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (73)
  • Transplantation (237)
  • Urology (206)